Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.

about

Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma.

P2860

Q41395870-D58F9867-9F24-46E4-8A46-6392035EEBE4

P2860

Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.

Item

http://www.wikidata.org/entity/Q53604757

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Interferon-alpha after autolog ...... h advanced Hodgkin's lymphoma.

@en

Interferon-alpha after autolog ...... h advanced Hodgkin's lymphoma.

@nl

type

Item

label

Interferon-alpha after autolog ...... h advanced Hodgkin's lymphoma.

@en

Interferon-alpha after autolog ...... h advanced Hodgkin's lymphoma.

@nl

prefLabel

Interferon-alpha after autolog ...... h advanced Hodgkin's lymphoma.

@en

Interferon-alpha after autolog ...... h advanced Hodgkin's lymphoma.

@nl

P1476

Interferon-alpha after autolog ...... h advanced Hodgkin's lymphoma.

@en

P2093

Chan KW

http://www.w3.org/2001/XMLSchema#string

Choroszy M

http://www.w3.org/2001/XMLSchema#string

Lockhart S

http://www.w3.org/2001/XMLSchema#string

Mullen CA

http://www.w3.org/2001/XMLSchema#string

Petropoulos D

http://www.w3.org/2001/XMLSchema#string

Worth LL

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease.

Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Interferons: mechanisms of action and clinical applications.

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Maintenance therapy with interferon alfa 2b in Hodgkin's disease.

Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial.

Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation.

P2888

sj.bmt.1705458

P304

345-349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1705458

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6873070

http://www.w3.org/2001/XMLSchema#string

P698

16915224

http://www.w3.org/2001/XMLSchema#string

Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.

about

P2860

P2860

Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698